Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 535,608 | 230,276 | 483,610 | 112,572 | 207,075 |
| Marketable Securities | 158,376 | 77,819 | 43,332 | 136,796 | 134,255 |
| Receivables | 954,967 | 693,120 | 103,035 | 81,917 | 65,568 |
| Inventories | 70,354 | 28,638 | N/A | N/A | N/A |
| Income taxes - deferred | 44,677 | 148,134 | 0 | N/A | N/A |
| TOTAL | $1,796,934 | $1,206,012 | $665,777 | $357,622 | $425,508 |
| Non-Current Assets | |||||
| PPE Net | 526,983 | 379,940 | 367,955 | 347,450 | 259,676 |
| Investments And Advances | 389,891 | 271,230 | 275,887 | 370,053 | 47,080 |
| Other Non-Current Assets | 237,205 | 223,308 | 13,964 | 14,307 | 8,938 |
| TOTAL | $1,154,079 | $874,478 | $657,806 | $731,810 | $315,694 |
| Total Assets | $2,951,013 | $2,080,490 | $1,323,583 | $1,089,432 | $741,202 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 250,896 | 111,345 | 95,625 | 53,658 | 49,031 |
| Other current liabilities | 939 | N/A | N/A | N/A | N/A |
| TOTAL | $298,835 | $163,550 | $148,271 | $109,056 | $93,575 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 47,000 | 50,831 | 51,640 | 54,723 | 44,544 |
| aiOther Non-Current Liabilities | 331,645 | 303,777 | 281,462 | 7,350 | 3,959 |
| TOTAL | $700,102 | $671,555 | $689,580 | $452,561 | $250,865 |
| Total Liabilities | $998,937 | $835,105 | $837,851 | $561,617 | $344,440 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 99,928 | 97,451 | 93,889 | 89,959 | 81,653 |
| Common Shares | 99 | 97 | 93 | 89 | 79 |
| Retained earnings | -92,692 | -517,054 | -1,267,323 | -1,045,563 | -941,095 |
| Other shareholders' equity | -1,188 | -1,166 | -1,862 | -2,491 | 1,046 |
| TOTAL | $1,952,076 | $1,245,385 | $485,732 | $527,815 | $396,762 |
| Total Liabilities And Equity | $2,951,013 | $2,080,490 | $1,323,583 | $1,089,432 | $741,202 |